Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Springdale. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Springdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that has spread from where it first started (primary site) to other places in the body (metastatic). Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by kill
Sponsor: SWOG Cancer Research Network
Check if you qualify for this prostate cancer clinical trial in Springdale, AR
If you're searching for prostate cancer treatment options in Springdale, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.